| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |